Here to listen, inform & support - For general enquiries call 01223-870008
Kidney Cancer News

Promise in US Trial for Advanced Metastatic RCC

New data from a Phase 1 clinical trial shows that ARMO BioSciences‘  immunotherapy AM0010 (pegilodecakin), alone or in combination with immune checkpoint inhibitors, shows high and durable clinical responses in patients with advanced renal cell carcinoma (RCC).

Vaccine for Renal Cancer Passes Early Test

A vaccine against metastatic renal cell carcinoma appears to have some activity in patients who receive engineered autologous dendritic cell infusions, researchers reported here at the International Kidney Cancer Symposium.
1 2 3 6